Brain Health: A Primary Health Care Viewpoint

Journal of the American Medical Directors Association

Volumn 16, Issue 9, 2015, Pages 720-721

  Wimo, Anders ^a   Winblad, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; COGNITIVE DEFECT; EDITORIAL; GENETIC SCREENING; HUMAN; MASS SCREENING; MILD COGNITIVE IMPAIRMENT; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; AGED; COGNITION DISORDERS; HEALTH CARE DELIVERY; PREVALENCE; PRIMARY HEALTH CARE; PROCEDURES;

AGED; COGNITION DISORDERS; DELIVERY OF HEALTH CARE; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY;

EID: 84940453502     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.06.012     Document Type: Editorial

References (10)

1. Morley J.E., Morris J.C., Berg-Weger M., et al. Brain health: The importance of recognizing cognitive impairment, an IAGG consensus conference. J Am Med Dir Assoc 2015, 16:722-723.
2. McKhann G.M., Knopman D.S., Chertkow H., et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:263-269.
3. Sperling R.A., Aisen P.S., Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7:280-292.
4. Ngandu T., Lehtisalo J., Solomon A., et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomized controlled trial. Lancet 2015, 385:2255-2263.
5. Zhang Y., Kivipelto M., Solomon A., Wimo A. Cost-effectiveness of a health intervention program with risk reductions for getting demented: Results of a Markov model in a Swedish/Finnish setting. J Alzheimers Dis 2011, 26:735-744.
6. Wimo A., Ballard C., Brayne C., et al. Health economic evaluation of treatments for Alzheimer's disease: Impact of new diagnostic criteria. J Intern Med 2014, 275:304-316.
7. Olafsdóttir M., Skoog I., Marcusson J. Detection of dementia in primary care: The Linköping study. Dement Geriatr Cogn Disord 2000, 11:223-229.
8. Wimo A., Jönsson L., Fratiglioni L., et al. Demenssjukdomarnas samhällskostnader i Sverige 2012 [The societal costs of dementia in Sweden 2012] 2014, Socialstyrelsen, Stockholm, Sweden, Swedish. Socialstyrelsen (Ed.).
9. Fox C., Lafortune L., Boustani M., et al. Screening for dementia: Is it a no brainer?. Int J Clin Pract 2013, 67:1076-1080.
10. Le Couteur D.G., Doust J., Creasey H., Brayne C. Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis. BMJ 2013, 347:f5125.